Litcius/Paper detail

Optimal management of neuromyelitis optica spectrum disorder with aquaporin-4 antibody by oral prednisolone maintenance therapy

Yoshiki Takai, Hiroshi Kuroda, Tatsuro Misu, Tetsuya Akaishi, Ichiro Nakashima, Toshiyuki Takahashi, Shuhei Nishiyama, Kazuo Fujihara, Masashi Aoki

2021Multiple Sclerosis and Related Disorders43 citationsDOI

Topics & Concepts

MedicinePrednisoloneNeuromyelitis opticaExpanded Disability Status ScaleInternal medicinePSLMedical recordPediatricsDosingCorticosteroidGastroenterologyAntibodyMultiple sclerosisImmunologyMathematicsGeometryMultiple Sclerosis Research StudiesVestibular and auditory disordersPeripheral Neuropathies and Disorders
Optimal management of neuromyelitis optica spectrum disorder with aquaporin-4 antibody by oral prednisolone maintenance therapy | Litcius